Thus, the interaction of PTX3 with the complement system to limit excessive complement activation may play a role under pathological conditions when the ECM is exposed during tissue injury, such as endothelial damage in hemolytic uremic syndrome or cartilage matrix exposure and degradation in rheumatoid arthritis [42], [44]–[46]. Here, PTX3 is linked to rheumatoid arthritis.